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Abstract
Background: Research has shown that patients with schizophrenia spectrum disorders (SSD) can
be distinguished from controls on the basis of their non-verbal expression. For example, patients
with SSD use facial expressions less than normals to invite and sustain social interaction. Here, we
sought to examine whether non-verbal expressivity in patients corresponds with their
impoverished social competence and neurocognition.
Method: Fifty patients with SSD were videotaped during interviews. Non-verbal expressivity was
evaluated using the Ethological Coding System for Interviews (ECSI). Social competence was
measured using the Social Behaviour Scale and psychopathology was rated using the Positive and
Negative Symptom Scale. Neurocognitive variables included measures of IQ, executive functioning,
and two mentalising tasks, which tapped into the ability to appreciate mental states of story
characters.
Results: Non-verbal expressivity was reduced in patients relative to controls. Lack of "prosocial"
nonverbal signals was associated with poor social competence and, partially, with impaired
understanding of others' minds, but not with non-social cognition or medication.
Conclusion: This is the first study to link deficits in non-verbal expressivity to levels of social skills
and awareness of others' thoughts and intentions in patients with SSD.
Background
Over the last 25 or so years, research into the nonverbal
behaviour of patients with schizophrenia or schizophre-
nia spectrum disorders (SSD) has demonstrated that
patients can be reliably distinguished from unaffected
individuals on the basis of their reduced expressivity [1-
3]. For example, microanalytic studies of facial move-
ments using the Facial Action Coding System (FACS) [4]
revealed that patients with schizophrenia are reduced in
their facial expressivity, particularly with regards to the
expression of positive emotions that are usually encoded
via movements of the upper part of the face [2,5]. Other
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studies carried out in more "naturalistic" settings on hos-
pital wards have shown that persons with schizophrenia
avoid physical proximity to others and display other defi-
cits in engaging in social interaction [1,6,7]. These studies
have in common that they are based on ethological meth-
odology. Ethological studies in normal populations have
shown that humans use facial expressions, gestures and
whole body movements to convey communicative signals
that invite social interaction (affiliation), reduce aggres-
sion through appeasement (submission), imply motiva-
tional ambivalence (fight or flight) or escalate social
competition [8-10]. These nonverbal signals during social
interaction are human universals that are to a great deal
encoded and understood in similar ways across cultures.
Since ethological studies have proven difficult to pursue
in psychiatric populations because they are fraught with
time-consuming analyses, a simpler method to examine
videotaped nonverbal behaviour in clinical settings was
introduced by Troisi et al. who developed a 37-item Etho-
logical Coding System for Interviews (ECSI) [11], based
on the work of Grant, McGuire and colleagues, as well as
Schelde et al. [6,7,12,13]. Troisi and coworkers observed
that unmedicated young males with schizophrenia could
be distinguished from normal controls on the basis of
their behavioural repertoire during interviews, including
the use of "prosocial" behaviours such as yes-nodding and
smiling, the use of gestures, and the amount of so-called
"displacement activities" as nonverbal signals of motiva-
tional conflict [11]. Even though facial and bodily expres-
sivity of patients with schizophrenia may be influenced by
neuroleptic dosage [14], or the presence of negative symp-
toms [15], it has recently been shown that SSD patients
treated with second-generation antipsychotics are reduced
in their expressive behaviour relative to controls, even
when medication is taken into account [16]. In particular,
patients with SSD send fewer signals of affiliation with
others, fewer affirmative expressions, and fewer signals
that convey the meaning of appeasement, which serve the
purpose to reduce interpersonal aggression. In general,
such prosocial patterns of behaviour are seen as nonverbal
signals that invite social interaction, which at least some
patients with SSD lack or use to a very limited extent
[3,16]. This reduction of non-verbal expressivity, particu-
larly the lack of prosocial signals, predicts functional dis-
ability in patients with schizophrenia [17], and correlates
to a certain extent with standard psychopathology meas-
ures, simply because such nonverbal behaviour consti-
tutes an important aspect of clinicians' ratings of
symptom severity [16].
Poor social competence in social interaction, in turn, has
been found to be uniquely associated with impaired
social cognition in patients with schizophrenia. Specifi-
cally, Brüne (2005) and Brüne et al. (2007) demonstrated
in independent samples of patients with schizophrenia
and SSD that an impaired ability to appreciate the mental
states of others, commonly referred to as "mentalising" or
"theory of mind", predicted poor social skills in patients
better than non-social cognition such as executive func-
tioning or intelligence [18,19]. Previous research has
revealed that patients with SSD are highly compromised
in their ability to comprehend mental states of others
[20]. Impaired mentalising abilities are most prominent
in patients with negative symptoms or disorganised
behaviour and partly independent of cognitive function-
ing [21-24]. Moreover, a mentalising deficit also pertains
to the broader schizophrenia phenotype and has been
demonstrated in otherwise healthy subjects with high
schizotypy scores [25,26].
With regards to the association of non-verbal expressivity
with social functioning on one hand, and the link of
social cognition with social competence in SSD on the
other hand, it is conceivable that patients' reduced proso-
cial expressivity is associated with their poor understand-
ing of others' minds. For example, a patient who is unable
to take into account her interlocutor's knowledge, inten-
tions, or desires that are different from her own may per-
haps (unconsciously) withhold nonverbal signals that are
usually expressed to facilitate communication and to
underscore the meaning of what is transmitted verbally.
The idea that reduced nonverbal expressivity could be
linked with patients' social-cognitive impairments and
their poor social competence has, to the best of our
knowledge, not been empirically examined so far. It is, of
course, unlikely that complex interpersonal behaviours
can be completely reduced to a single factor such as the
ability to attribute mental states to others. In any event, we
were interested in the question whether nonverbal behav-
iour would at least correlate with independent raters'
impression of patients' social skills, standard measures of
psychopathology, and particularly social (as well as non-
social) neurocognition. Specifically, we hypothesised that
patients with SSD would differ from healthy controls in
terms of non-verbal expressivity and (social and non-
social) neurocognition; we further hypothesised that the
SSD patients with poor prosocial behaviour would dis-
play reduced social skills in social interaction, as inde-
pendently rated by nursing staff, and impaired social
cognitive abilities relative to patients with preserved non-
verbal expressivity, but would not necessarily differ with
respect to other (non-social) neurocognitive domains.
Methods
Participants
50 in-patients (22 males, 28 females) diagnosed with
schizophrenia (N = 38), schizoaffective disorder (N = 9)
and delusional disorder (N = 3) according to DSM-IV-TR
criteria [27] were included. All patients were in sub-acuteBehavioral and Brain Functions 2009, 5:6 http://www.behavioralandbrainfunctions.com/content/5/1/6
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stages of their illnesses such that they were able to give full
informed consent in writing and to complete the neu-
ropsychological test battery. Patients with a history of sub-
stance abuse, severe brain injury or mental retardation
were excluded. All patients received second-generation
antipsychotic substances (SGA). The mean chlorpro-
mazine equivalent dosage (CPZ) as determined according
to Wood's suggestions [28] was 667.73 (SD ± 603 mg) per
day. For comparisons, 30 healthy controls (10 males, 20
females) were included, paralleled for age and sex distri-
bution. The study was approved by the Ethics Committee
of the University of Bochum.
Patients' mean age was 39.24 (SD ± 13.55), their mean
age at onset of SSD was 29.29 years (SD ± 13.99) and their
average duration of illness was 9.85 years (SD ± 8.79). The
mean age of the control group was 36.83 (SD ± 13.53).
No differences between the groups were found with
respect to sex distribution (chi2 = .889, df = 1, Fisher's
exact test, p = .48, n.s.) or age (t = .77, df = 78, p = .444,
n.s.). Group comparisons for demographic variables, cog-
nitive performance as well as PANSS ratings and social
competence scores for patients are shown in Table 1.
Behavioural assessment
Ethological assessment of non-verbal expressivity
Non-verbal expressivity of patients and controls was eval-
uated using the Ethological Coding System for Interviews
(ECSI) [3]. The ECSI comprises 37 different patterns of
behaviour, eight of which are summarised under the term
"prosocial behaviour". Prosocial behaviours embrace
both patterns of behaviour that invite and positively reas-
sure social interaction (referred to as "affiliation") and
behaviours signalling appeasement that are used to pre-
vent aggression in social interactions (termed "submis-
sion"). Accordingly, non-verbal expressions of
prosociality included: "head to side" movements; "bob",
a sharp upwards movement of the head, similar to an
inverted nod; "flash", a quick raising and lowering of the
eyebrows; "raise", a movement where the eyebrows are
raised and kept up for some time; "smile", where the lip
corners are typically drawn back and up; "nod", as affirm-
ative gesture; "lips in", characterised by drawing the lips
slightly inwards and pressing the lips together; and
"mouth corners back", which describes the drawing back
of the corners of the mouth without raising the mouth
angles as in smiling, thus, signalling attenuated fear. The
ECSI was specifically designed for measuring nonverbal
behaviour during interviews based on published human
Table 1: Demographic characteristics and performance of patients with SSD and controls
Patients Healthy Controls Sign.
mean SD mean SD
N 50 30
M:F 22:28 10:20 .480
Age 39.24 13.55 36.83 13.53 .444
MWT (IQ) 103.9 13.34 111 13.55 .024
Picture Completion 11.1 3.48 13.67 2.2 < .001
Zoo Map 0 3.23 4.41 3.55 < .001
WCST pers. 3.18 3.3 0.93 1.39 < .001
Mechanical 21.24 2.85 23.27 1.51 .001
Social script 21.56 3.07 23.03 2.17 .008
Capture 13.82 5.07 16.7 4.17 .014
False belief 16.2 5.45 21.43 2.81 < .001
Sequencing (Brüne) 28.0 6.65 33.83 2.59 < .001
Questionnaire 18.86 3.81 21.9 1.37 < .001
Mentalising II total 46.82 8.97 55.53 3.53 < .001
Duration of illness 9.85 8.79
PANSS positive 14.92 5.49
PANSS negative 17.48 8.62
PANSS disorganisation 22.02 6.36
PANSS excitement 6.42 2.62
PANSS affective sympt. 10.82 3.46
PANSS sum 71.74 16.43
Social Behaviour 13.7 8.84Behavioral and Brain Functions 2009, 5:6 http://www.behavioralandbrainfunctions.com/content/5/1/6
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ethograms that have revealed universal non-verbal expres-
sions in social interaction [8,29].
The interviews carried out by three female psychologists
were videotaped with a camera such that the subjects'
faces were in full view. To ascertain optimal evaluation,
two trained observers simultaneously examined the vide-
otapes for the presence or absence of each of the behav-
ioural items in successive 15-second intervals. As
suggested by Troisi [3], we used a one-zero (i.e. present-
versus-absent in a 15-second interval) sampling method
for recording the results, which has been shown to highly
correlate with both frequency and duration measures of
the same behaviour in previous studies. To avoid distrac-
tion of the evaluation process by verbal material the video
player was turned mute during the scoring procedure.
Moreover, to maximise accuracy, if disagreement between
the two raters occurred with regards to any one rating
interval, the respective time interval was re-examined
until a consensus decision could be achieved. The overall
duration of the videotaped part of the interview was 10
minutes (thus, 40 15-second sampling intervals alto-
gether) during which the interviewer collected as much
information as possible for rating the subjects' psychopa-
thology using the Positive and Negative Symptom Scale
(PANSS) [30]. We chose this setting for both groups to
improve comparability of group results, even though this
procedure might arguably have created greater or even less
emotional involvement in patients compared to healthy
controls. For further analyses, the scores of individual
behaviours for each subject are expressed as the propor-
tion of intervals during which the behavioural pattern
occurred.
Social behaviour and social competence
Patients' social behaviour and social competence were
rated by an experienced nursing staff member who was
most familiar with the patients' actual behaviour in social
interactions using the Social Behaviour Scale (SBS) [31].
The SBS represents a 21-item rating scale comprising com-
municative skills, socially inappropriate behaviours,
autistic symptoms (muttering, laughing to self), affective
symptoms (anxiety, restlessness, depression), and move-
ment disorders (bizarre behaviour, mannerisms, postur-
ing). Each item is rated according to the severity of
deviation on a Likert-type scale ranging from "0" (absent)
to "4" (severe).
Psychopathology
Psychopathology was rated using the Positive and Nega-
tive Syndrome Scale (PANSS) [30]. Here, we chose a novel
five-factor model of the PANSS [32] instead of the classic
three-factor model, because the former has been shown to
have superior statistical validity, and because we were spe-
cifically interested in the question whether ratings of non-
verbal behaviour and social competence would correlate
with any one of these more specific factors (e.g., positive,
negative, disorganised, excitement and affective). All rat-
ings of psychopathology and social behaviour were car-
ried out blind to the patients' performance on the social
and non-social neurocognitive tasks.
Neurocognition
Non-social cognition
Verbal intelligence was assessed using the German "Mehr-
fachwahl-Wortschatz-Test", that is, "Multiple Choice
Vocabulary Test" (MWT) [33], which resembles the "Spot-
the-Word-Test" [34]. The MWT is believed to index pre-
morbid intelligence in patients with psychiatric disorders.
Non-verbal intelligence was assessed using the Picture
Completion Task, a subtest of the "Wechsler Adult Intelli-
gence Scale", revised German version (WAIS-R) [35].
To assess executive functioning skills we used the Zoo
Map Test from the Behavioral Assessment of the Dysexec-
utive Syndrome battery (BADS) [36] to assess executive
planning. The first part of the Zoo Map test requires par-
ticipants to mentally plan a route through a zoo drawn on
a map while taking into account given rules such as not to
take a certain trail twice. The second part of the test simply
requires participants to follow detailed instructions con-
cerning how to find their way through the zoo terrain. We
used the score from the more challenging first part of the
Zoo Map Test for further analyses.
Cognitive flexibility was also assessed using a simplified
computer version of the Wisconsin Card Sorting Test
(WCST) [37]. The number of perseverative errors on this
task was used for further analyses.
Social cognition
The ability to appreciate mental states was examined first
using a non-verbal "false-belief" picture-sequencing task
in which, for each false-belief story sequence, four cartoon
pictures depict a story character who acts on the basis of a
mistaken belief concerning the true location of a certain
critical item (e.g. a story character is ignorant about the
true location of an item which had been moved or errone-
ously blames another character for having moved the
item). These false-belief sequences were first developed by
Langdon et al. [21] and have since been used in non-clin-
ical and clinical schizotypal samples to demonstrate men-
talising deficits [25,26]. In addition to the four false-belief
sequences, 12 additional sequences, also comprising four
pictures per sequence and developed by Langdon and
Coltheart [25], depicted "mechanical", "social-script",
and "capture" stories. The mechanical sequences illus-
trated simple physical cause-and-effect events (such as a
stone rolling down a slope); the social script sequences
depicted interacting characters without the necessity toBehavioral and Brain Functions 2009, 5:6 http://www.behavioralandbrainfunctions.com/content/5/1/6
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infer the mental states of these characters; the capture
sequences were designed to test the ability to suppress
salient misleading information in favour of less salient
but more relevant information that eventually led to cor-
rect sequencing. In contrast to previous studies using this
task, the administration was computerised such that each
sequence of four pictures was presented in a jumbled
order to the participants on a computer screen. The partic-
ipants were asked to move the pictures using a computer
mouse until they were certain that the sequencing of the
four pictures showed a logical order of events. Prior to the
experimental sequences, which were presented in a ran-
dom order for each participant, two practice sequences
were presented to ensure that all participants had fully
understood the procedure. Scoring was according to Lang-
don et al.'s suggestions [21], that is, for each sequence,
two points were given for the first and last correctly posi-
tioned pictures, and one point each for correct positioning
of the two middle pictures. Accordingly, participants
could obtain a maximum of 6 points per sequence, thus
24 points per sequence type (i.e. false-belief, mechanical,
social-script or capture).
In addition, a second cartoon series tapping into mental-
ising abilities was given to the participants. Six cartoon
picture stories depict: (1) two scenarios involving co-oper-
ation of two characters, (2) two scenarios illustrating
deliberate deception of one character by another, and (3)
two scenarios showing two characters cooperating at the
cost of a third one. The administration procedure was sim-
ilar to our previous studies [18,19], with the notable dif-
ference that pictures and subsequent questions were
depicted on a computer screen instead of the previously
used paper and pencil version. As above, each picture
story consisted of four cards, which were presented in a
mixed-up order. The participants' positioning of pictures
was scored as per Langdon et al.'s series. In addition to the
non-verbal component of this task (i.e. the sequencing of
the pictures), the participants also answered 23 questions
probing understanding of the mental states of the story
characters. These questions included mentalising ques-
tions ranging from first to third-order complexity and
requiring true and false correct answers, as well as ques-
tions probing the understanding of intended deception,
cheating, and cooperation. Whenever the participant
failed to sequence the story correctly, the picture story was
re-arranged correctly by the experimenter before the ques-
tions pertaining to the story were asked. Total scores for
sequencing (36 pts. maximum) and for responses to the
questionnaire (23 pts. maximum) were calculated (thus
59 pts. altogether).
Statistical analysis
Wherever skewness and kurtosis of the variables were
within acceptable ranges, we used student's t-tests for
group comparisons. For non-normally distributed varia-
bles we used non-parametric Mann-Whitney-U tests. Uni-
variate analyses of variance with covariates were carried
out to examine the specificity of mentalising deficits in the
patient group. To examine associations of psychopathol-
ogy and medication with non-verbal behaviours in the
patient group we calculated parametric correlation coeffi-
cients. Analyses were performed using SPSS for Macin-
tosh, version 13.0.
Results
Between-group differences
Comparisons between patients with SSD and controls
revealed significant differences with regards to non-verbal
expressivity and neurocognition (both social and non-
social). Social competence and psychopathology were
rated in patients only. Patients displayed significantly
fewer prosocial behaviours (t = -5.072, df = 78, p < .001)
– that is, such behaviours were present in only 21.38 per-
cent of the sampling intervals for patients compared to
29.46 percent for controls.
Moreover, in terms of cognitive performance patients with
SSD had lower IQ scores, both verbal (premorbidly) (t = -
2.308, df = 78, p = .024) and non-verbal (Mann-Whitney-
U = 384.5, Z = -3.466, p = .001). They also performed
more poorly than controls on the executive planning task
(i.e. Zoo Map; t = 5.642, df = 77, p < .001), and were cog-
nitively less flexible (Mann-Whitney-U = 296.0, Z = -
4.373, p < .001) compared to controls as determined
using the number of perseverative errors in the WCST.
Similar to previous studies, patients with SSD performed
more poorly on all sequencing tests of mentalising. On
the first sequencing task, patients obtained lower scores
on the non-social control stories – mechanical (Mann-
Whitney-U = 435.5, Z = -3407, p = .001), social script
(Mann-Whitney-U = 514.5, Z = -2.646, p = .008), and cap-
ture (Mann-Whitney-U = 503.5, Z = -2.464, p = .014) – as
well as on the false belief stories (Mann-Whitney-U =
321.5, Z = -4.292, p < .001). Similarly, patients scored
lower on the sequencing part of the Brüne [18,19] car-
toons' task (Mann-Whitney-U = 333.5, Z = -4.213, p <
.001). They also made more errors in answering the men-
talising questions (Mann-Whitney-U = 326.5, Z = -4.276,
p < .001), and thus had lower total scores for this task
(Mann-Whitney-U = 263.0, Z = -4.855, p < .001).
Although not optimally suitable for non-normally distrib-
uted variables, we also conducted ANCOVAs (which are
nevertheless very robust procedures) to investigate
whether or not the mentalising deficits in the SSD patients
were selective, i.e. independent of the non-social cognitive
impairment. We therefore entered both measures of IQ,
executive functioning variables, and the different non-Behavioral and Brain Functions 2009, 5:6 http://www.behavioralandbrainfunctions.com/content/5/1/6
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social sequencing scores (i.e. mechanical, social script and
capture scores) as covariates in the equations (one at a
time) for both the false-belief picture-sequencing scores
and the mentalising score according to Brüne (2005).
Notably, the mentalising deficits in SSD remained signifi-
cantly different from controls in every condition. Table 2
shows the results for each covariate.
Correlations within the patient group
To determine associations of non-verbal expressivity with
measures of social competence, neurocognitive variables
(social and non-social) and standard psychopathological
ratings within the patient group, we calculated parametric
correlation coefficients. Accordingly, non-verbal expres-
sivity correlated negatively with the PANSS disorganisa-
tion score (r = -.294, p = .038). There were also negative
associations of prosocial behaviour with the PANSS posi-
tive symptoms score (r = -.256, p = .073), with the PANSS
negative symptom score (r = -.273, p = .055), with Lang-
don's false-belief sequencing score (r = .241, p = .091),
with the questionnaire part of Brüne's mentalising task (r
= .26, p = .069), with the total mentalising score from
Brüne's task (r = .236, p = .099), and with the social
behaviour score as determined using the SBS (r = -.273, p
= 0.69); however, all these associations failed to reach sta-
tistical significance. By contrast, there were multiple corre-
lations between measures from the two sequencing tasks,
between neurocognitive measures and the social behav-
iour score, and, in part, with psychopathology. Specifi-
cally, only Langdon's false-belief sequencing score (r = -
.479, p = .001) and Brüne's mentalising scores (all p's <
.01) correlated significantly with the social behaviour
score, as did the number of perseverative errors on the
WCST (r = -.524, p < .001). Moreover, the PANSS disor-
ganisation score correlated significantly with several of the
sequencing task scores and with the social behaviour
measure. Medication levels did not correlate with any one
of the other variables (correlations are displayed in addi-
tional file 1).
Differences between patients with low and high levels of 
non-verbal expressivity
Since we were particularly interested in the possible asso-
ciations between nonverbal expressivity and both social
competence and social cognitive performance of patients
with SSD, and in light of the relatively weak correlations
of non-verbal expressivity with these various measures, we
compared the patients falling into the lowest quartile with
the patients falling into the highest quartile of non-verbal
expressivity with regards to the neurocognitive (social and
non-social) and behavioural measures. We chose this pro-
cedure based on the hypothesis that patients who scored
lowest according to the ethological coding system would
perhaps do so because of more difficulties in understand-
ing other minds, when compared to patients with high
scores on non-verbal expressivity, who, according to our
hypothesis would have a preserved understanding of
other minds, and would therefore be relatively unim-
paired in social interaction.
Accordingly, patients with the least prosocial behaviour
(N = 14) displayed, on average, prosocial expressions of
affiliation or submission in only 11.9 per cent (± 1.8) of
observed intervals. In contrast, patients with high levels of
prosocial behaviour (N = 12) showed affiliative or sub-
missive expressions in 33.41 per cent (± 4.04) of intervals.
Thus, high "prosocials" were well within the range of non-
verbal expressivity of healthy controls.
Most interestingly, when comparing low prosocials with
high prosocials within the patient sample, we found a sig-
nificant group difference with regards to the false-belief
sequencing score (t = -2.041, df = 24, p = .05), while the
group difference for the total sequencing and question-
naire score from the second mentalising task approached
significance (t = -2.007, df = 24, p = .06). In contrast, no
differences between high and low prosocial patients
emerged in any one of the other cognitive tasks. As would
be expected, however, the patient groups differed with
regards to psychopathology scores (i.e. PANSS positive,
negative, and disorganised subscores). In addition, low
prosocial patients had significantly less social compe-
tence, that is, higher scores on the SBS, compared with
patients with high prosocial expressivity (t = 2.133, df =
20, p = .05). Results are summarised in Table 3.
Table 2: Results of the ANCOVAs concerning selectivity of 
mentalising deficits in patients compared with controls (upper 
row: False belief task, lower row: mentalising II task)
Covariate df Mean square F Statistics
no covariate 1 513.521 23.794 p < .001
1 1423.541 25.793 p < .001
MWT IQ 1 389.528 18.647 p < .001
1 1060.207 20.099 p < .001
Picture completion 1 193.606 10.599 p = .002
1 467.812 10.899 p = .001
WCST pers. 1 219.384 12.430 p = .001
1 550.198 12.262 p = .001
Zoo Map 1 129.732 6.565 p = .012
1 382.938 7.671 p = .007
Mechanical 1 208.275 11.615 p = .001
697.903 14.168 p < .001
Social script 1 358.326 17.886 p < .001
1 947.784 19.246 p < .001
Capture 1 265.561 15.493 p < .001
1 928.654 18.313 p < .001
MWT: Mehrfachwahl-Wortschatz-Test (verbal or premorbid IQ); 
WCST pers.: number of perseverative errors in the Wisconsin Card 
Sorting Test.Behavioral and Brain Functions 2009, 5:6 http://www.behavioralandbrainfunctions.com/content/5/1/6
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Discussion
In the present study we sought to explore the associations
of nonverbal expressive behaviour with social compe-
tence and neurocognition (social and non-social) in
patients with SSD. Specifically, we were interested in the
question whether reduced non-verbal expression of
behaviours that invite social communication, referred to
as prosocial behaviours [3], would be linked with poorer
social competence and impaired understanding of mental
states in patients with SSD.
In line with previous studies [11,16], we were able to
show that patients with SSD were reduced in their non-
verbal expressivity during an interview that aimed at
exploring psychopathological symptoms and subjective
factors of distress when compared to controls, paralleled
for age and gender, who were observed during a similar
interview. Moreover, patients' social competence was
associated with levels of executive functioning and men-
talising abilities, a finding that mirrors previous results
from a clinical sample that overlaps somewhat with the
present study [19]. As expected, patients were also signifi-
cantly less able than controls to appreciate the mental
Table 3: Comparison of task performance between patients with low non-verbal expressivity ("low prosocials") and patients with high 
(normal) nonverbal expressivity ("high prosocials")
Parameter Group Mean SD sign.
Age Low prosocials 41.29 14.66 p = .131
High prosocials 33.5 9.78
Duration of illness Low prosocials 9.93 9.4 p = .731
High prosocials 8.73 7.36
Intelligence MWT Low prosocials 102.64 11.93 p = .502
High prosocials 106.25 15.06
Picture completion Low prosocials 11.07 3.08 p = .993
High prosocials 11.08 4.23
Executive functioning WCST pers. Low prosocials 3.69 2.84 p = .109
High prosocials 2.17 1.47
Zoo Map Low prosocials -0.93 3.95 p = .075
High prosocials 1.75 3.28
Langdon et al.'s sequencing tasks Mechanical Low prosocials 21.07 2.9 p = .087
High prosocials 22.67 1.5
Social script Low prosocials 20.64 2.85 p = .075
High prosocials 22.75 2.93
Capture Low prosocials 13.5 4.78 p = .419
High prosocials 15.08 5.02
False belief Low prosocials 15.86 4.88 p = .05
High prosocials 19.75 4.81
Mentalising Task II Sequencing Low prosocials 27.5 6.67 p = .133
High prosocials 31.08 4.72
Questionnaire Low prosocials 18.43 3.84 p = .071
High prosocials 20.83 2.33
Total score Low prosocials 45.57 9.04 p = .06
High prosocials 51.83 6.38
Positive and Negative Symptom Scale positive Low prosocials 18.43 4.59 p = .004
High prosocials 13.17 3.74
negative Low prosocials 21.07 7.77 p = .027
High prosocials 14.5 6.23
disorganised Low prosocials 24.07 5.66 p = .007
High prosocials 17.83 4.97
excitement Low prosocials 5.86 1.66 p = .546
High prosocials 6.25 1.6
affective Low prosocials 12.07 3.79 p = .111
High prosocials 9.82 2.27
Social Competence (SBS) Low prosocials 16.64 10.41 p = .05
High prosocials 8.73 6.54
Chlorpromazine equivalents Low prosocials 794.14 838.91 p = .551
High prosocials 621.09 491.64
MWT: Mehrfachwahl-Wortschatz-Test (verbal or premorbid IQ); WCST pers.: number of perseverative errors in the Wisconsin Card Sorting 
Test.Behavioral and Brain Functions 2009, 5:6 http://www.behavioralandbrainfunctions.com/content/5/1/6
Page 8 of 10
(page number not for citation purposes)
states of story characters. The mentalising deficit appeared
to be selective in SSD, although the statistical analysis of
covariance was not optimally suited for the evaluation of
this question. Nevertheless the follow-up comparison of
low and high prosocial patients was consistent with the
suggestion of selectivity of mentalising deficit in the
patients.
The most important question of the present study was,
however, to examine whether or not patients' nonverbal
expressive behaviour would be associated with their social
competence as rated by carers who were oblivious to the
study design, and whether nonverbal expressivity would
be linked with the patients' neurocognitive (social and
non-social) abilities. The basic hypotheses motivating this
question were that patients with SSD who are less able to
understand others' minds would display not only more
behavioural abnormalities as measured using the Social
Behaviour Scale [31], but also reduced nonverbal expres-
sivity that normally invites social interaction, i.e. proso-
cial behaviours. Both hypotheses were partially
confirmed. Even though nonverbal expressivity did not
correlate with any one of the neurocognitive (social or
non-social) variables or with social competence at a 0.05
significance level, we found that patients with the lowest
level of nonverbal expressivity performed more poorly on
a false-belief mentalising task compared with patients
whose nonverbal expressivity during interviews was
within the range of healthy controls. Moreover, the asso-
ciation of reduced prosociality with scores from a second
mentalising task approached significance. In contrast, all
other differences between low and high prosocials were
inconspicuous (perhaps with the exception of executive
planning, where the level of significance was .075). As
expected, there were also significant differences between
low and high prosocials with regards to standard meas-
ures of psychopathology, which underscores the relevance
of patients' nonverbal behaviour for clinicians' ratings of
symptom severity [16]. Moreover, low and high proso-
cials also differed significantly in social behavioural skills.
These associations are entirely compatible with the find-
ing reported elsewhere that impaired mentalising is the
best predictor of poor social competence in patients with
SSD and has greater explanatory power than executive
functioning or IQ [19]. Notably, in the present study no
correlation of any one variable was found with medica-
tion levels, which can perhaps best be accounted for by
treatment with second-generation antipsychotic sub-
stances.
To the best of our knowledge, this is the first study to link
nonverbal expressive behaviour in patients with SSD with
other measures of interpersonal functioning and neuro-
cognitive (social and non-social) performance. The find-
ing that nonverbal expressivity could be associated with
the ability to mentalise has not been previously reported.
There has been considerable speculation about the cause
of reduced behavioural expressivity in patients with SSD.
The most obvious though superficial explanation is that
reduced expressivity is a direct consequence of the severity
of negative symptoms, a notion that is partially consistent
with our results [38]. However, the largest negative corre-
lation with regards to standard psychopathology meas-
ures was found between nonverbal expressivity and
patients' level of behavioural and cognitive disorganisa-
tion and not with the level of negative symptoms. Previ-
ous studies [24,39] and a recent meta-analysis [23] have
revealed that mentalising is most severely impaired in
patients with disorganised symptomatology. It is there-
fore conceivable that poor mentalising abilities contribute
to patients' reduced use of nonverbal behaviours that
invite and sustain social interaction in dyadic conversa-
tions, and that reduced signals of this type then contrib-
ute, in part, to clinicians' severity ratings of negative
symptoms during (dyadic) clinical interviews.
Limitations
The present study does not allow causal explanations.
Rather, it is limited in explanatory power to correlational
associations and differences between extremes of varia-
tion with regards to nonverbal expressivity within the
patient group. This might in the first place be a result of
the heterogeneity of the sample in terms of symptomatol-
ogy. Moreover, findings may not be generalisable to
patients in symptomatic remission. Ideally (and this
ought to be addressed in future studies), a similar study in
a more homogenous sample of patients with prominent
disorganised symptoms may yield even more promising
results. Likewise, a future study that allows for finer-
grained discrimination of severities of different types of
negative symptoms would be informative. Finally, it
would be interesting to explore in greater detail how non-
verbal expressivity is related to self-reflection, because
self-reflexive awareness has been shown to play a role in
both attribution of mental states to others and social func-
tioning in SSD and other severe mental disorders [40].
Conclusion
Linking neurocognition (particularly social cognition)
with real-world behaviour (particularly nonverbal expres-
sion) has been a relatively neglected issue in clinical
research to date. The present study is thus important in
seeking to better specify the factors that actually guide and
motivate patients' interpersonal nonverbal behaviour.
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